Covid-19 Research

Editorial

Multifaceted Medical and Scientific Approaches and the Role of the Public in Combating the COVID-19 Pandemic in the Digital Era

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Editorial
Subject Medicine Group
OCLC 9038785953
Vijay Mahant*
Issue: Volume2-Issue1
Pages: 008-010
Received: 2021-01-07
Accepted: 2021-01-08
Published: 2021-01-11

Abstract

Epidemics and pandemics have been recurrent in history. One of the worst pandemics in the modern history was the 1918 H1N1 flu (“Spanish flu”) that claimed the lives of an estimated 50 million people globally [1]. The current pandemic, a severe acute respiratory syndrome coronavirus (SARS-CoV-2), the etiologic agent of COVID-19, was first reported in the city of Wuhan (China) in December 2019. According to the World Health Organization (WHO), at the time of writing, there were over 84 million confirmed cases and over 1.8 million deaths in 218 countries linked to COVID-19 [2], and the numbers of cases continue to climb globally. The viral transmission has been reported as predominantly horizontal while reports of vertical transmission have been limited [3]. The impact of COVID-19 on morbidity, mortality, lifestyle changes, and trillions of dollars in the economy is unprecedented in the modern history. There are significant synergies and a concerted role for multifaceted medical and scientific approaches to be utilized to engage the public in combating COVID-19 effectively.

FullText HTML FullText PDF DOI: 10.37871/jbres1179 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2020 Mahant V. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Vijay M. Multifaceted Medical and Scientific Approaches and the Role of the Public in Combating the COVID-19 Pandemic in the Digital Era. J Biomed Res Environ Sci. 2021 Jan 11; 2(1): 008-010. doi: 10.37871/jbres1179, Article ID: jbres1179

Subject area(s)

OncologyPain and ReliefCardiovascular DiseasesClinical Cardiology

References

  1. Center for Disease Control. 1918 Pandemic (H1N1 Virus). 2021 January 02.
  2. WHO Coronavirus Disease (COVID-19) Dashboard. 2021 January 6.
  3. Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O, Taylor HS, Tal R. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021 Jan;224(1):35-53.e3. doi: 10.1016/j.ajog.2020.07.049. Epub 2020 Jul 31. PMID: 32739398; PMCID: PMC7392880.
  4. Azer SA. COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. 2020 Sep;37:100738. doi: 10.1016/j.nmni.2020.100738. Epub 2020 Aug 5. PMID: 32834902; PMCID: PMC7403867.
  5. Jabri A, Kalra A, Kumar A, Alameh A, Adroja S, Bashir H, Nowacki AS, Shah R, Khubber S, Kanaa’N A, Hedrick DP, Sleik KM, Mehta N, Chung MK, Khot UN, Kapadia SR, Puri R, Reed GW. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020 Jul 1;3(7):e2014780. doi: 10.1001/jamanetworkopen.2020.14780. PMID: 32644140; PMCID: PMC7348683.
  6. Becker RC. Anticipating the long-term cardiovascular effects of COVID-19. J Thromb Thrombolysis. 2020 Sep 3;1–13. doi:10.1007/s11239-020-02266-6. PMID: 32880795; PMCID: PMC7467860.
  7. Shakil MH, Munim ZH, Tasnia M, Sarowar S. COVID-19 and the environment: A critical review and research agenda. Sci Total Environ. 2020 Nov 25;745:141022. doi: 10.1016/j.scitotenv.2020.141022. Epub 2020 Jul 17. PMID: 32711074; PMCID: PMC7366970.
  8. Paden CR, Tao Y, Queen K, Zhang J, Li Y, Uehara A, Tong S. Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020 Oct;26(10):2401-2405. doi: 10.3201/eid2610.201800. Epub 2020 Jul 1. PMID: 32610037; PMCID: PMC7510745.
  9. US Food and Drug Administration. In Vitro Diagnostics EUAs. 2021 January 2.
  10. US Food and Drug Administration. Pfizer-BioNTech COVID-19 Vaccine. 2021 January 4.
  11. US Food and Drug Administration. Moderna COVID-19 Vaccine. 2021 January 2
  12. US Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19. 2021 January 4.
  13. US Food and Drug Administration. FDA Approves First Treatment for COVID-19. 2020 December 21.
  14. AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK. 2020 December 30.
  15. Bio Covid-19 Therapeutic Development Tracker. 2021January 5.
  16. Covid Resource Center. 2021 January 4.
  17. Bragazzi NL, Dai H, Damiani G, Behzadifar M, Martini M, Wu J. How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 Pandemic. Int J Environ Res Public Health. 2020 May 2;17(9):3176. doi: 10.3390/ijerph17093176. PMID: 32370204; PMCID: PMC7246824.
  18. Reeves JJ, Longhurst CA, San Miguel SJ, Juarez R, Behymer J, Ramotar KM, Maysent P, Scioscia AL, Millen M. Bringing student health and Well-Being onto a health system EHR: the benefits of integration in the COVID-19 era. J Am Coll Health. 2020 Nov 12;1-7. doi: 10.1080/07448481.2020.1843468. Epub ahead of print. PMID: 33180683.
  19. Alkhowailed M, Shariq A, Alqossayir F, Alzahrani OA, Rasheed Z, Abdulmonem WAl.Impact of meteorological parameters on COVID-19 pandemic: A comprehensive study from Saudi Arabia. Informatics in Medicine Unlocked.2020;Volume 20:100418. doi: 10.1016/j.imu.2020.100418.
  20. US Food and Drug Administration has cleared the use of behold.ai’s red dot® algorithm for ‘instant triage’ in radiology. 2021 January 2.
  21. BlueDot for Healthcare. We help protect frontline workers and patients, increase diagnostic acumen, and build organizational resilience. 2021 January 2.
  22. Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012 Jan-Feb;3(1):4-14. doi: 10.4161/gmic.19320. Epub 2012 Jan 1. PMID: 22356853; PMCID: PMC3337124.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership